Clinical trial
Inflammatory Activation, Epigenetic Signature and Morpho-structural Alteration in a Cohort of Patients With Chronic Heart Failure and Permanent Non-valvular Atrial Fibrillation: a Cross-sectional Study
NCT07152301 is registered in ClinicalTrials.gov with University of Palermo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Inflammatory Activation, Epigenetic Signature and Morpho-structural Alteration in a Cohort of Patients With Chronic Heart Failure and Permanent Non-valvular Atrial Fibrillation: a Cross-sectional Study
- Lead sponsor
- University of Palermo
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- May 31, 2022
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (permanent), congestive heart failure chronic